Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
ACS Chemical Biology|November 5, 2016
Elucidating the Rimosamide-Detoxin Natural Product Families and Their Biosynthesis Using Metabolite/Gene Cluster CorrelationsRyan A McClure, Anthony W Goering, Kou-San Ju, et al.Molecular Cancer Research : MCR|May 15, 2024
MYC Family Amplification Dictates Sensitivity to BET Bromodomain Protein Inhibitor Mivebresib (ABBV075) in Small-Cell Lung CancerJoshua P Plotnik, Zheng Zha, Weiguo Feng, et al.ACS Central Science|May 11, 2016
Metabologenomics: Correlation of Microbial Gene Clusters with Metabolites Drives Discovery of a Nonribosomal Peptide with an Unusual Amino Acid MonomerAnthony W Goering, Ryan A McClure, James R Doroghazi, et al.ACS Chemical Biology|March 7, 2018
Discovery of the Tyrobetaine Natural Products and Their Biosynthetic Gene Cluster via MetabologenomicsElizabeth I Parkinson, James H Tryon, Anthony W Goering, et al.Journal of Proteome Research|January 27, 2025
Automated High-Throughput Affinity Capture-Mass Spectrometry Platform with Data-Independent AcquisitionHui Jing, Paul L Richardson, Gregory K Potts, et al.ACS Chemical Biology|May 17, 2022
Targeting IRAK3 for Degradation to Enhance IL-12 Pro-inflammatory Cytokine ProductionAnn Rowley, Brian S Brown, Mary Stofega, et al.Frontiers in Pharmacology|December 26, 2025
Off-target autophagy disruption associated with a novel liver toxicity in dogs for a highly basic heterobifunctional protein degraderJames E Kath, Rebecca Kohnken, Timothy Brayman, et al.ACS Chemical Biology|July 9, 2024
Quantitative Measurement of Rate of Targeted Protein DegradationThomas L Lynch, Violeta L Marin, Ryan A McClure, et al.ACS Chemical Biology|February 21, 2022
The HPK1 Inhibitor A-745 Verifies the Potential of Modulating T Cell Kinase Signaling for ImmunotherapySven Malchow, Alla Korepanova, Sanjay C Panchal, et al.Molecular Cancer Therapeutics|March 20, 2024
Inhibition of MALT1 and BCL2 Induces Synergistic Antitumor Activity in Models of B-Cell LymphomaJoshua P Plotnik, Adam E Richardson, Haopeng Yang, et al.Pageof 2